Felzartamab (anti-CD38) in patients with IgA Nephropathy-interim results from the IGNAZ study

被引:0
|
作者
Floege, Juergen [1 ]
Lafayette, Richard [2 ]
Barratt, Jonathan [3 ]
Schwartz, Brian [4 ]
Manser, Paul T. [4 ]
Patel, Uptal D. [4 ]
Pineda, Lilia [4 ]
Faulhaber, Nicola [5 ]
Boxhammer, Rainer [5 ]
Haertle, Stefan [5 ]
Thakur, Anjali [5 ]
Barbour, Sean [6 ]
机构
[1] RWTH Aachen Univ Hosp, Div Nephrol & Cardiol, Aachen, Germany
[2] Stanford Glomerular Dis Ctr, Palo Alto, CA USA
[3] Univ Leicester, Leicester, Leics, England
[4] Human Immunol Biosci Inc, San Francisco, CA USA
[5] MorphoSys AG, Planegg, Germany
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
425
引用
收藏
页码:I252 / I253
页数:2
相关论文
共 50 条
  • [41] Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
    Mohyuddin, Ghulam Rehman
    Chakraborty, Rajshekhar
    Calip, Gregory S.
    Ascha, Mustafa S.
    Wang, Xiaoliang
    Rubinstein, Samuel M.
    Tuchman, Sascha
    Costa, Luciano
    Haaland, Benjamin
    Giri, Smith
    Mian, Hira
    Fonseca, Rafael
    Sborov, Douglas
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (12)
  • [42] Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
    Ghulam Rehman Mohyuddin
    Rajshekhar Chakraborty
    Gregory S. Calip
    Mustafa S. Ascha
    Xiaoliang Wang
    Samuel M. Rubinstein
    Sascha Tuchman
    Luciano Costa
    Benjamin Haaland
    Smith Giri
    Hira Mian
    Rafael Fonseca
    Douglas Sborov
    [J]. Blood Cancer Journal, 12
  • [43] Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method
    Stanic, Hana Safic
    Galic, Zrinka Kruhonja
    Lukic, Martina
    Bingulac-Popovic, Jasna
    Jukic, Irena
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2024, 63 (02)
  • [44] Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
    Chiu, Chia-Yu
    Patel, Krina
    Thomas, Sheeba K.
    Khawaja, Fareed
    Garnes, Natalie J. M. Dailey
    Lee, Hans C.
    Ohanian, Maro
    Jiang, Ying
    Wang, Lan S.
    Hwang, Jessica P.
    Torres, Harrys A.
    [J]. HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 509 - 511
  • [45] A phase Ib study of TAK-079, an investigational anti-CD38 monoclonal antibody (mAb) in patients with relapsed/ refractory multiple myeloma (RRMM): Preliminary results.
    Krishnan, Amrita Y.
    Patel, Krina K.
    Hari, Parameswaran
    Jagannath, Sundar
    Niesvizky, Ruben
    Silbermann, Rebecca Wang
    Berg, Deborah T.
    Li, Qing
    Allikmets, Kristina
    Stockerl-Goldstein, Keith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Reduced binding of immunoglobulin A (IgA) from patients with IgA nephropathy to the myeloid IgA FC - Receptor, CD89.
    vanZandbergen, G
    vanKooten, C
    Mohamad, NK
    Reterink, TJF
    vanWinkel, JGJ
    Daha, MR
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2174 - A2174
  • [47] Reduced binding of immunoglobulin A (IgA) from patients with IgA nephropathy, to the myeloid IgA FC receptor, CD89.
    van Zandbergen, G
    van Kooten, C
    Mohamad, NK
    Reterink, TJF
    de Fijter, JW
    van de Winkel, JGJ
    Daha, MR
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1160 - 1160
  • [48] INTERIM RESULTS FROM AN ONGOING PHASE 2 STUDY EVALUATING THE USE OF A MASP-2 INHIBITOR FOR THE TREATMENT OF IGA NEPHROPATHY (IGAN)
    Barratt, Jonathan
    Leifke, Eckhard
    Whitaker, Steve
    DeTulleo, Louis
    Lafayette, Richard
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [49] GEN3014 (HexaBody ®-CD38) in Anti-CD38 Mab-Naive Patients with Relapsed/Refractory Multiple Myeloma: Preliminary Results from a Dose-Expansion Cohort of a Phase 1/2 Trial
    Grosicki, Sebastian
    Plesner, Torben
    Jurczak, Wojciech
    Radocha, Jakub
    Malek, Ehsan
    Hiemstra, Ida
    Brady, Lauren K.
    Chen, Jenny
    Gong, Nian
    Hindsberger, Charlotte
    Spencer, Andrew
    [J]. BLOOD, 2023, 142
  • [50] Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity -: elevated levels in serum of tumour patients
    Korkut, Ç
    Yalçintepe, L
    Kiremit-Korkut, N
    Uzun-Altinöz, S
    Issever, S
    Gümüsel, F
    Tiryaki, D
    Bermek, E
    [J]. CANCER LETTERS, 1998, 126 (01) : 105 - 109